The Chemours Company (CC) Q1 2025 Earnings Call May 07, 2025 08:00 AM ET Company Participants Brandon Ontjes - Vice President of FP&A and Investor RelationsDenise Dignam - President & CEOShane Hostetter - SVP & CFOJohn Roberts - Managing DirectorJosh Spector - Executive Director Conference Call Participants John McNulty - MD - Chemicals AnalystPeter Osterland - Equity Research AnalystNone - AnalystLaurence Alexander - AnalystArun Viswanathan - Senior Equity AnalystDuffy Fischer - AnalystMichael Leithead - A ...

The Chemours Company (CC) Q1 2025 Earnings Call May 07, 2025 08:00 AM ET Speaker0 Good morning. My name is Michelle, I will be your conference operator today. I would like to welcome everyone to the Chemours Company First Quarter and Full Year twenty twenty five Results Conference Call. Currently, all participants are in a listen only mode. A question and answer session will follow the conclusion of the prepared remarks. I would like to remind everyone that this conference call is being recorded. I would no ...

Core Insights - Magnera reported a strong financial performance for Q2 of fiscal 2025, with net sales reaching $824 million, a 48% increase compared to $558 million in Q2 2024, driven by the Glatfelter merger [3][4][21] - The company emphasized its resilience amid global economic uncertainties and is focused on executing strategic priorities for integration and long-term growth [2][3] - Adjusted EBITDA for the quarter was $89 million, reflecting a 17% increase from $76 million in the same quarter last year [3][5][21] Financial Performance - Net sales for the year-to-date (YTD) period reached $1.526 billion, up 42% from $1.077 billion in the previous year [3][21] - Operating income for Q2 was $4 million, down from $21 million in Q2 2024, while YTD operating loss was $(18) million compared to a profit of $9 million last year [3][21] - The increase in net sales was partially offset by a $26 million unfavorable impact from foreign currency changes and a decline in volume [4][5] Segment Performance - In the Americas segment, net sales increased by $124 million due to the Glatfelter merger, despite a $15 million negative impact from foreign currency changes [6][7] - The Rest of World segment saw a net sales increase of $187 million, also influenced by the Glatfelter merger, but faced a $11 million unfavorable impact from currency changes and a 3% volume decline [8] Cash Flow and Debt - Cash flow from operating activities for Q2 was $65 million, with post-merger adjusted free cash flow at $42 million [10][11] - Total debt as of March 29, 2025, was $1.998 billion, with total net debt at $1.716 billion and a leverage ratio of 3.9x [11][24] Guidance - The company provided guidance for fiscal 2025, projecting full-year comparable adjusted EBITDA in the range of $360 million to $380 million and post-merger adjusted free cash flow between $75 million and $95 million [14][27]

Industry Overview - The chemicals industry has faced significant challenges over the past year, including weak industrial demand, a slowdown in China, and chronic excess supply [1] - These factors have resulted in weak pricing and slow volumes within the industry [1] Company Specifics - Chemours (NYSE: CC) is mentioned as being affected by the overall industry conditions, although specific performance metrics for Chemours are not detailed in the provided text [1]

For the quarter ended March 2025, Chemours (CC) reported revenue of $1.37 billion, up 1.3% over the same period last year. EPS came in at $0.13, compared to $0.32 in the year-ago quarter.The reported revenue represents a surprise of +0.94% over the Zacks Consensus Estimate of $1.36 billion. With the consensus EPS estimate being $0.19, the EPS surprise was -31.58%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectatio ...

2 Safe Harbor Statement and Other Matters This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words "believe," "expect," "will," "anticipate," "plan," "est ...

Core Viewpoint - Ecovyst Inc. has successfully acquired the sulfuric acid production assets from Cornerstone Chemical Company, enhancing its capacity and supply reliability in the sulfuric acid market [1][2]. Company Overview - Ecovyst Inc. is a global provider of advanced materials, specialty catalysts, virgin sulfuric acid, and sulfuric acid regeneration services, with a focus on sustainability [3]. - The company operates through two main business segments: Ecoservices, which provides sulfuric acid recycling and high-quality virgin sulfuric acid, and Advanced Materials & Catalysts, which offers finished silica catalysts and specialty zeolites [4]. Acquisition Details - The acquisition of the Waggaman, Louisiana assets is expected to increase network flexibility and supply reliability, addressing future growth in demand for virgin sulfuric acid and regeneration services [2]. - The integration of Cornerstone's assets is anticipated to enhance Ecovyst's operational capabilities and customer service [2].

Powell Industries, Inc. (POWL) is scheduled to release second-quarter fiscal 2025 (ended March 31, 2025) results on May 6, after market close.The company has an impressive earnings surprise history, the average beat being 33.3%. In the last reported quarter, its earnings of $2.86 per share surpassed the Zacks Consensus Estimate of $2.83 by 1.1%. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)Let’s see how things have shaped up for Powell this earnings season.Key Factors and Estimat ...

Core Insights - Avient reported revenue of $826.6 million for the quarter ended March 2025, a decrease of 0.3% year-over-year, with EPS remaining unchanged at $0.76 [1] - The revenue fell short of the Zacks Consensus Estimate of $833.46 million, resulting in a surprise of -0.82%, while the EPS exceeded the consensus estimate of $0.75 by 1.33% [1] Financial Performance Metrics - Specialty Engineered Materials sales were $308.40 million, below the average estimate of $312.56 million, reflecting a year-over-year decline of 1.9% [4] - Color, Additives and Inks sales reached $519.70 million, slightly below the average estimate of $521.10 million, with a year-over-year increase of 0.9% [4] - Corporate sales reported a loss of -$1.50 million, worse than the average estimate of -$0.80 million, marking a significant year-over-year change of +114.3% [4] Operating Income Analysis - Operating income for Color, Additives and Inks was $78.60 million, slightly above the average estimate of $78.01 million [4] - Operating income for Specialty Engineered Materials was $47.10 million, below the average estimate of $49.71 million [4] - Corporate operating loss was -$125 million, significantly worse than the average estimate of -$32.27 million [4] Stock Performance - Avient's shares have returned +13.9% over the past month, outperforming the Zacks S&P 500 composite's +11.5% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Celanese (CE) Q1 2025 Earnings Call May 06, 2025 09:00 AM ET Company Participants Bill Cunningham - Vice President of Investor RelationsDavid Begleiter - DirectorScott Richardson - President & CEOFrank Mitsch - PresidentVincent Andrews - Managing DirectorChuck Kyrish - Senior VP & CFOJoshua Spector - Executive DirectorMichael Sison - Managing DirectorKevin McCarthy - PartnerJohn Roberts - Managing DirectorMatthew Blair - Managing Director Conference Call Participants Jeffrey Zekauskas - AnalystGhansham Panj ...